Antimicrob Agents Chemother. • 2019.04.25
Emeraud C., Escaut L., Boucly A., et al.
Lancet Infect Dis • 2019.09.25
Kollef M.H., Nová?ek M., Kivistik Ü., et al.
- Clinical trial
- International
- Ceftolozane-tazobactam, Clinical trial, Drug therapy, Meropenem, Nosocomial Pneumonia
Antibiotics • 2022.05.06
Caffrey A.R., Appaneal H.J., Liao J.X., et al.
BMJ Case Reports • 2021.02.05
Arumairaj A., Agarwal S., Popli T., et al.
Clinical Microbiology and Infection • 2021.09.18
Tong S.Y.C, Lewis R.J., Morpeth S.C.
Antimicrobial Agents and Chemotherapy • 2021.11.08
Wüllner D., Gesper M., Haupt A., et al.
- Bacterial mechanisms, New antibiotics and alternatives
- International
- Azithromycin, Ceftazidime, Ciprofloxacin, Colistin, Gentamicin, Levofloxacin, Lipopolysaccharide biosynthesis inhibitors, Meropenem, Piperacillin, Polymyxin B, Pseudomonas aeruginosa, Rifampicin, Tazobactam, Tigecycline, Tobramycin
Antimicrobial Chemotherapy • 2022.03.22
Poirel L., Ortiz de la Rosa J.M., Sadek M., et al.
Clinical Microbiology and Infection • 2022.06.27
Danjean M., Amaris Hobson C., Gits-Muselli M., et al.